Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Benzethidine is a synthetic opioid analgesic of the 4-phenylpiperidine class, structurally related to pethidine (meperidine). It acts as a mu-opioid receptor agonist and produces typical opioid effects such as analgesia, sedation, nausea, and respiratory depression. Despite its pharmacological activity, benzethidine has never been used clinically due to safety concerns and high abuse potential. It is classified as a Schedule I controlled substance in the United States and under similar restrictions internationally; this means it has no accepted medical use and carries a high risk for abuse[1][2][5]. The compound was investigated experimentally but was ultimately forbidden for use[7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on benzethidine.